Canadian Cancer Trials Group Bulletins


CE.6 Trial Published in New England Journal of Medicine

Canadian Cancer Trials Group CE.6 Clinical Trial published in the New England Journal of Medicine
Study finds that adding temozolomide chemotherapy to short-course radiation therapy improves overall survival for older patients.

The Canadian Cancer Trials Group (CCTG) led CE.6 phase III trial was published today in the New England Journal of Medicine. This international study tested the addition of temozolomide chemotherapy to an abbreviated course of radiation therapy in older adults with Glioblastoma (brain cancer). Read more.

Also see local media coverage.